Survival and quality of life of testicular cancers;Survie et qualite de vie des cancers du testicule

Annales d'Urologie

Volumn 32, Issue 2, 1998, Pages 80-82

  Delpon, P M L ^a   Petit, M ^a   Houlgatte, A ^a   Droz, J P ^a  

^a FOCH HOSPITAL   (France)

Author keywords

Carcinoma in situ; Chemotherapy; Fertility; Germ cell tumour; Retroperitoneal lymph node dissection; Testis

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; ETOPOSIDE;

CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; HUMAN; LYMPH NODE DISSECTION; PATERNITY; QUALITY OF LIFE; REVIEW; TESTIS CANCER; ADULT; LYMPHADENECTOMY; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; PSYCHOLOGICAL ASPECT; SURVIVAL; TESTIS TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; HUMANS; LYMPH NODE EXCISION; MALE; PROGNOSIS; QUALITY OF LIFE; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 0031627244     PISSN: 00034401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)